Paul Kaiser
@paulkaiser.bsky.social
Healthcare Social Media Strategist exploring new ideas, sound science, and inspiration from the world around me. Passionate about #Science, #Tech, #AI, #DataAnalysis, #DataVisualization, and a #DigitalIntervention! https://www.digitalintervention.com/
#TOP-LINE RESULTS FROM ROCATINLIMAB #PHASE3 IGNITE STUDY IN ADULTS with MODERATE TO SEVERE ATOPIC DERMATITIS prn.to/4hlA38A
AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new results from the ongoing ROCKET Phase 3 clinical...
prn.to
March 11, 2025 at 1:52 PM
#TOP-LINE RESULTS FROM ROCATINLIMAB #PHASE3 IGNITE STUDY IN ADULTS with MODERATE TO SEVERE ATOPIC DERMATITIS prn.to/4hlA38A
Reposted by Paul Kaiser
February 11, 2025 at 2:25 PM
Reposted by Paul Kaiser
We are rapidly approaching Rare Disease Month, and this year it's more important than ever to raise awareness. Because rare is many. Rare is strong. Rare is proud. #RareDiseaseDay2025
youtu.be/fIvqxQPjisI?...
youtu.be/fIvqxQPjisI?...
Rare Disease Day 2025 official video
YouTube video by Rare Disease Day
youtu.be
January 29, 2025 at 2:34 AM
We are rapidly approaching Rare Disease Month, and this year it's more important than ever to raise awareness. Because rare is many. Rare is strong. Rare is proud. #RareDiseaseDay2025
youtu.be/fIvqxQPjisI?...
youtu.be/fIvqxQPjisI?...
Reposted by Paul Kaiser
Want to learn more about botensilimab and balstilimab treatment safety and efficacy in patients with #ColorectalCancer? Check out the phase 1 trial results published in #NatureMedicine last year #GI25 #OncSky #Immunotherapy
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial - Nature Medicine
In an ongoing phase 1 trial, the combination of two new immunotherapies targeting CTLA-4 and PD-1 was overall well tolerated and elicited encouraging clinical responses in patients with relapsed/refra...
www.nature.com
January 25, 2025 at 5:40 PM
Want to learn more about botensilimab and balstilimab treatment safety and efficacy in patients with #ColorectalCancer? Check out the phase 1 trial results published in #NatureMedicine last year #GI25 #OncSky #Immunotherapy
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Paul Kaiser
#GISeries: #Zanidatamab was recently approved based off #HerizonBTC01! We 🗣️ design, findings, sequencing and AEs/management with Dr. Shubham Pant
Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast
#OncSky #MedSky #gism #GI25
Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast
#OncSky #MedSky #gism #GI25
January 3, 2025 at 1:28 AM
#GISeries: #Zanidatamab was recently approved based off #HerizonBTC01! We 🗣️ design, findings, sequencing and AEs/management with Dr. Shubham Pant
Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast
#OncSky #MedSky #gism #GI25
Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast
#OncSky #MedSky #gism #GI25
Reposted by Paul Kaiser
#GI25 @ascocancer.bsky.social
Two trials on the tissue factor⛔️, pamrevlumab (PAM) in #PancreaticCancer, both by Dr. Piccozzi:
1⃣LAPIS, a R-Ph3 trial of chemo +/- PAM for LAPC, Oral Abstract #675
2⃣The Precision Promise trial @pancan.bsky.social of PAM+gem/nab-pac for mPDAC, Oral Abstract # 673
Two trials on the tissue factor⛔️, pamrevlumab (PAM) in #PancreaticCancer, both by Dr. Piccozzi:
1⃣LAPIS, a R-Ph3 trial of chemo +/- PAM for LAPC, Oral Abstract #675
2⃣The Precision Promise trial @pancan.bsky.social of PAM+gem/nab-pac for mPDAC, Oral Abstract # 673
January 11, 2025 at 6:54 PM
#GI25 @ascocancer.bsky.social
Two trials on the tissue factor⛔️, pamrevlumab (PAM) in #PancreaticCancer, both by Dr. Piccozzi:
1⃣LAPIS, a R-Ph3 trial of chemo +/- PAM for LAPC, Oral Abstract #675
2⃣The Precision Promise trial @pancan.bsky.social of PAM+gem/nab-pac for mPDAC, Oral Abstract # 673
Two trials on the tissue factor⛔️, pamrevlumab (PAM) in #PancreaticCancer, both by Dr. Piccozzi:
1⃣LAPIS, a R-Ph3 trial of chemo +/- PAM for LAPC, Oral Abstract #675
2⃣The Precision Promise trial @pancan.bsky.social of PAM+gem/nab-pac for mPDAC, Oral Abstract # 673
Discover how it transforms insights into actionable strategies in our latest blog: bit.ly/4h0iZWD
🩺 Smarter campaigns
📊 Key tools
✨ Real-world impact
#SocialListening #MarketingInsights #Healthcare
🩺 Smarter campaigns
📊 Key tools
✨ Real-world impact
#SocialListening #MarketingInsights #Healthcare
Social Listening in Rare Diseases: A Game-Changer for Patient Advocacy and Pharma Strategy - Digital Intervention
Rare diseases often fly under the radar, affecting small patient populations and garnering limited public attention. Yet for those living with these conditions, the challenges are immense—delayed diag...
bit.ly
January 19, 2025 at 2:37 AM
Discover how it transforms insights into actionable strategies in our latest blog: bit.ly/4h0iZWD
🩺 Smarter campaigns
📊 Key tools
✨ Real-world impact
#SocialListening #MarketingInsights #Healthcare
🩺 Smarter campaigns
📊 Key tools
✨ Real-world impact
#SocialListening #MarketingInsights #Healthcare
Social listening in 2025 will evolve with AI-driven insights, predictive analytics, and ethical practices. From niche communities to visual & voice data, brands must stay ahead to connect authentically. #SocialListening #AI #DigitalMarketing #2025Trends #EthicalTech www.linkedin.com/pulse/future...
The Future of Social Listening in 2025: What’s Next?
As we step into 2025, social listening is poised to evolve in groundbreaking ways, reshaping how brands engage with their audiences. The confluence of advanced technologies like artificial intelligenc...
www.linkedin.com
January 2, 2025 at 6:34 PM
Social listening in 2025 will evolve with AI-driven insights, predictive analytics, and ethical practices. From niche communities to visual & voice data, brands must stay ahead to connect authentically. #SocialListening #AI #DigitalMarketing #2025Trends #EthicalTech www.linkedin.com/pulse/future...
🎉 Happy New Year from Digital Intervention! 🎉
Here’s to new opportunities, continued growth, and making a difference together!
✨ Wishing you a year filled with health, happiness, and success. Let’s make 2025 extraordinary!
#HappyNewYear #DigitalIntervention #SocialListening #2025
Here’s to new opportunities, continued growth, and making a difference together!
✨ Wishing you a year filled with health, happiness, and success. Let’s make 2025 extraordinary!
#HappyNewYear #DigitalIntervention #SocialListening #2025
January 1, 2025 at 3:30 AM
🎉 Happy New Year from Digital Intervention! 🎉
Here’s to new opportunities, continued growth, and making a difference together!
✨ Wishing you a year filled with health, happiness, and success. Let’s make 2025 extraordinary!
#HappyNewYear #DigitalIntervention #SocialListening #2025
Here’s to new opportunities, continued growth, and making a difference together!
✨ Wishing you a year filled with health, happiness, and success. Let’s make 2025 extraordinary!
#HappyNewYear #DigitalIntervention #SocialListening #2025
Google just released a new feature called Deep Research, part of the Gemini 2.0 release, that helps you do research online. It's like having a personal AI assistant that can find information for you and write a report. #AIInnovation #aihealthcare #digitalintervention
blog.google/products/gem...
blog.google/products/gem...
Try Deep Research and our new experimental model in Gemini, your AI assistant
Try Deep Research, a new research assistant in Gemini Advanced, and a chat optimized version of Gemini 2.0 Flash Experimental.
blog.google
December 13, 2024 at 2:14 AM
Google just released a new feature called Deep Research, part of the Gemini 2.0 release, that helps you do research online. It's like having a personal AI assistant that can find information for you and write a report. #AIInnovation #aihealthcare #digitalintervention
blog.google/products/gem...
blog.google/products/gem...
Reposted by Paul Kaiser
Wow, PATINA shows 15 month improved PFS in 1st line HER-2 when palbociclib is added to ET +HER-2 antibodies in maintenance 1st line setting after chemo induction.
👏
#bcsm
#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social
www.businesswire.com/news/home/20...
👏
#bcsm
#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social
www.businesswire.com/news/home/20...
Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer
Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) today announced results from the Phase 3 PATINA trial demonstrating that the addition
www.businesswire.com
December 12, 2024 at 3:45 PM
Wow, PATINA shows 15 month improved PFS in 1st line HER-2 when palbociclib is added to ET +HER-2 antibodies in maintenance 1st line setting after chemo induction.
👏
#bcsm
#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social
www.businesswire.com/news/home/20...
👏
#bcsm
#SABCS24
@sabcs.bsky.social
@oncoalert.bsky.social
www.businesswire.com/news/home/20...
Reposted by Paul Kaiser
I created a SABCS Breast Thought Leader Starter Pack for anyone new to @bsky.app and following @sabcs.bsky.social
Will try to add all thought leaders as I go!
go.bsky.app/MkqBYa7
Will try to add all thought leaders as I go!
go.bsky.app/MkqBYa7
December 9, 2024 at 5:26 PM
I created a SABCS Breast Thought Leader Starter Pack for anyone new to @bsky.app and following @sabcs.bsky.social
Will try to add all thought leaders as I go!
go.bsky.app/MkqBYa7
Will try to add all thought leaders as I go!
go.bsky.app/MkqBYa7
And so it begins....#SABC24
We are looking forward to this year's San Antonio Breast Cancer Symposium which starts on December 10. Take a look at the full program for this important meeting featuring the latest research on breast cancer. sabcs.org/FullProgram #SABCS24 #breastcancer
December 10, 2024 at 10:54 PM
And so it begins....#SABC24
Reposting for those just coming into social and #Blusky Welcome to #ASH24 The hashtags work on Bluesky and on that other platform #Xsky
The ASH annual meeting starts the end of this week and they have published some helpful #hASHtags and info for those following on #TheSocials
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
December 8, 2024 at 12:37 AM
Welcome, ASH!
December 3, 2024 at 7:44 PM
6 platforms to engage #ASH24 during the conference.
FACEBOOK - www.facebook.com/AmericanSoci...
INSTAGRAM - www.instagram.com/ash_hematolo...
LINKEDIN - www.linkedin.com/company/amer...
X - x.com/ASH_hematology
YOUTUBE - www.youtube.com/@AmericanSoc...
BLUESKY - @ash-hematology.bsky.social
FACEBOOK - www.facebook.com/AmericanSoci...
INSTAGRAM - www.instagram.com/ash_hematolo...
LINKEDIN - www.linkedin.com/company/amer...
X - x.com/ASH_hematology
YOUTUBE - www.youtube.com/@AmericanSoc...
BLUESKY - @ash-hematology.bsky.social
December 3, 2024 at 1:11 AM
6 platforms to engage #ASH24 during the conference.
FACEBOOK - www.facebook.com/AmericanSoci...
INSTAGRAM - www.instagram.com/ash_hematolo...
LINKEDIN - www.linkedin.com/company/amer...
X - x.com/ASH_hematology
YOUTUBE - www.youtube.com/@AmericanSoc...
BLUESKY - @ash-hematology.bsky.social
FACEBOOK - www.facebook.com/AmericanSoci...
INSTAGRAM - www.instagram.com/ash_hematolo...
LINKEDIN - www.linkedin.com/company/amer...
X - x.com/ASH_hematology
YOUTUBE - www.youtube.com/@AmericanSoc...
BLUESKY - @ash-hematology.bsky.social
The ASH annual meeting starts the end of this week and they have published some helpful #hASHtags and info for those following on #TheSocials
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
December 2, 2024 at 9:56 PM
The ASH annual meeting starts the end of this week and they have published some helpful #hASHtags and info for those following on #TheSocials
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
#ASHKY #SocialListening #DigitalIntervention #ASH24 #OncologyEducation
Discover the power of social listening! Monitor online conversations to uncover trends, track brand sentiment, & understand your audience. It's more than just data—it's actionable insights for smarter strategies. Stay ahead & let your audience guide your next big move! #SocialListening
November 27, 2024 at 3:07 AM
Discover the power of social listening! Monitor online conversations to uncover trends, track brand sentiment, & understand your audience. It's more than just data—it's actionable insights for smarter strategies. Stay ahead & let your audience guide your next big move! #SocialListening
Maximize congress listening by tracking live discussions, analyzing sentiment, and identifying key influencers. Insight: Post-session buzz often reveals unmet needs and emerging trends. Don’t just listen—turn insights into strategy! #CongressListening #HealthcareInnovation #digitalintervention
November 26, 2024 at 2:59 AM
Maximize congress listening by tracking live discussions, analyzing sentiment, and identifying key influencers. Insight: Post-session buzz often reveals unmet needs and emerging trends. Don’t just listen—turn insights into strategy! #CongressListening #HealthcareInnovation #digitalintervention
Excited for #ASH24! 🔬✨ Major data releases from @bmsnews, @merck, & @AstraZeneca on cutting-edge therapies in hematology. From CAR-T updates to novel T-cell engagers, the future of blood cancer treatment. Dec 7-10 in San Diego. #sociallistening #digitalintervention #oncsky #medsky #Hematology
November 26, 2024 at 2:34 AM
Excited for #ASH24! 🔬✨ Major data releases from @bmsnews, @merck, & @AstraZeneca on cutting-edge therapies in hematology. From CAR-T updates to novel T-cell engagers, the future of blood cancer treatment. Dec 7-10 in San Diego. #sociallistening #digitalintervention #oncsky #medsky #Hematology
Some great info and medical organizations to follow here on #Blsky #medsky #Cardiosky #DigitalIntervention
#AHA24 #CardioSky #MedSky
AHA @americanheart.bsky.social
ACC @accintouch.bsky.social
AHA Sciences @ahascience.bsky.social
AHA Journals @ahajournals.bsky.social
JAMA @jamacurrent.bsky.social
ASPC @aspcardio.bsky.social
Am J Prev Card @ajpcardio.bsky.social
J Card Fail @jcardfail.bsky.social
AHA @americanheart.bsky.social
ACC @accintouch.bsky.social
AHA Sciences @ahascience.bsky.social
AHA Journals @ahajournals.bsky.social
JAMA @jamacurrent.bsky.social
ASPC @aspcardio.bsky.social
Am J Prev Card @ajpcardio.bsky.social
J Card Fail @jcardfail.bsky.social
November 20, 2024 at 5:43 PM
Some great info and medical organizations to follow here on #Blsky #medsky #Cardiosky #DigitalIntervention
The eXodus to #Blsky and why. What's next?
bit.ly/3CycdrQ
#DigitalIntervention #socialmedia #Healthcare #shiftinsocialmedia
bit.ly/3CycdrQ
#DigitalIntervention #socialmedia #Healthcare #shiftinsocialmedia
The Exodus from X to Bluesky: Healthcare Professionals Leading the Shift - Digital Intervention
The migration from X (formerly Twitter) to Bluesky by healthcare professionals (HCPs) highlights an evolving need for reliable, professional, and user-centered digital platforms. Bluesky’s recent grow...
bit.ly
November 20, 2024 at 5:37 PM
The eXodus to #Blsky and why. What's next?
bit.ly/3CycdrQ
#DigitalIntervention #socialmedia #Healthcare #shiftinsocialmedia
bit.ly/3CycdrQ
#DigitalIntervention #socialmedia #Healthcare #shiftinsocialmedia